Living with neuromyelitis optica spectrum disorder (NMOSD) often means navigating a journey filled with both triumphs and challenges. While some days I feel that I’m managing the disease well, I quietly suffer on others. For loved ones and caregivers, understanding the subtle signs that indicate a rough day for…
NMOSD symptoms
Nearly 1 in 5 people with neuromyelitis optica spectrum disorder (NMOSD) experience early neurological symptoms prior to their first established NMOSD attack, new research suggests. These symptoms could represent an NMOSD prodrome, a disease stage where nonspecific symptoms emerge before the classic manifestations of the disease. A better…
The clinical symptoms of neuromyelitis optica spectrum disorder (NMOSD) in people in their 50s or older may look like those of a stroke — which can delay proper diagnosis and treatment of the the progressive autoimmune disorder, according to a case report and systematic literature review. That’s what happened…
Note: This column describes the author’s own experiences with medical marijuana products. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Living in Colorado is a dream for many reasons, including the fact that there are over 300…
The presence of lesions in the brain’s middle medulla, a control center for breathing, increases the likelihood of acute respiratory failure in people with neuromyelitis optica spectrum disorder (NMOSD), a study suggests. While middle medullary lesions on MRI were the key predictor of acute respiratory failure in patients with…
A small subset of people with neuromyelitis optica spectrum disorder (NMOSD) do not accumulate significant functional disability in the 15 years following symptom onset, according to a recent study. Called benign NMOSD, these patients were more likely to be Caucasian, less likely to have spinal cord involvement at disease…
Recent Posts
- Every time I turn to Dr. Google, I get an immune system mystery
- Conventional NMOSD treatment effective in double-negative cases
- Grieving how NMOSD has left me uncomfortable in my own skin
- Enspryng outperforms standard immunosuppressants in NMOSD study
- Slow and steady: I’m ditching big resolutions and easing into a new year
- Late-onset NMOSD responds better to newer, highly effective therapies
- New biomarker may help gauge disease severity in NMOSD
- The longest night of the year offers hope of brighter days with NMOSD
- Advanced plasma exchange therapy effectively eases NMOSD attacks
- Reaffirming that access to healthcare is a human right